Pharmacological treatments in ARDS; a state-of-the-art update

Despite its high incidence and devastating outcomes, acute respiratory distress syndrome (ARDS) has no specific treatment, with effective therapy currently limited to minimizing potentially harmful ventilation and avoiding a positive fluid balance. Many pharmacological therapies have been investigat...

Descripción completa

Detalles Bibliográficos
Autores principales: Boyle, Andrew James, Sweeney, Rob Mac, McAuley, Daniel Francis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3765621/
https://www.ncbi.nlm.nih.gov/pubmed/23957905
http://dx.doi.org/10.1186/1741-7015-11-166
_version_ 1782283352655527936
author Boyle, Andrew James
Sweeney, Rob Mac
McAuley, Daniel Francis
author_facet Boyle, Andrew James
Sweeney, Rob Mac
McAuley, Daniel Francis
author_sort Boyle, Andrew James
collection PubMed
description Despite its high incidence and devastating outcomes, acute respiratory distress syndrome (ARDS) has no specific treatment, with effective therapy currently limited to minimizing potentially harmful ventilation and avoiding a positive fluid balance. Many pharmacological therapies have been investigated with limited success to date. In this review article we provide a state-of-the-art update on recent and ongoing trials, as well as reviewing promising future pharmacological therapies in ARDS.
format Online
Article
Text
id pubmed-3765621
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-37656212013-09-11 Pharmacological treatments in ARDS; a state-of-the-art update Boyle, Andrew James Sweeney, Rob Mac McAuley, Daniel Francis BMC Med Review Despite its high incidence and devastating outcomes, acute respiratory distress syndrome (ARDS) has no specific treatment, with effective therapy currently limited to minimizing potentially harmful ventilation and avoiding a positive fluid balance. Many pharmacological therapies have been investigated with limited success to date. In this review article we provide a state-of-the-art update on recent and ongoing trials, as well as reviewing promising future pharmacological therapies in ARDS. BioMed Central 2013-08-20 /pmc/articles/PMC3765621/ /pubmed/23957905 http://dx.doi.org/10.1186/1741-7015-11-166 Text en Copyright © 2013 Boyle et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Boyle, Andrew James
Sweeney, Rob Mac
McAuley, Daniel Francis
Pharmacological treatments in ARDS; a state-of-the-art update
title Pharmacological treatments in ARDS; a state-of-the-art update
title_full Pharmacological treatments in ARDS; a state-of-the-art update
title_fullStr Pharmacological treatments in ARDS; a state-of-the-art update
title_full_unstemmed Pharmacological treatments in ARDS; a state-of-the-art update
title_short Pharmacological treatments in ARDS; a state-of-the-art update
title_sort pharmacological treatments in ards; a state-of-the-art update
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3765621/
https://www.ncbi.nlm.nih.gov/pubmed/23957905
http://dx.doi.org/10.1186/1741-7015-11-166
work_keys_str_mv AT boyleandrewjames pharmacologicaltreatmentsinardsastateoftheartupdate
AT sweeneyrobmac pharmacologicaltreatmentsinardsastateoftheartupdate
AT mcauleydanielfrancis pharmacologicaltreatmentsinardsastateoftheartupdate

Ejemplares similares